These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29629740)

  • 1. Vascular effects of simvastatin are similar to hormone replacement therapy in postmenopausal women.
    Ociepka A; Milewicz T; Kialka M; Krzyczkowska-Sendrakowska M
    Przegl Lek; 2016; 73(5):280-6. PubMed ID: 29629740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
    Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
    Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The somatotropic axis in postmenopausal women during six month of transdermal continuous 17beta-estradiol administration combined with oral medroxyprogesterone.
    Milewicz T; Krzysiek J; Rogatko I; Sztefko K; Stochmal E; Hubalewska-Dydejczyk A; Jach R; Radowicki S
    Ginekol Pol; 2011 Apr; 82(4):254-8. PubMed ID: 21721462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous versus cyclical transdermal oestrogen replacement therapy in postmenopausal women: effects on lipoprotein(a) and nitric oxide levels.
    Serin IS; Aygen EM; Başbuğ M; Saraymen R; Narin F; Tayyar M
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):447-9. PubMed ID: 11787924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
    Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
    Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
    Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
    Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
    Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study.
    Battaglia C; Mancini F; Persico N; Penacchioni P; Regnani G; Volpe A; de Aloysio D
    Maturitas; 2004 Aug; 48(4):446-55. PubMed ID: 15283938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
    Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of sex hormones on serum levels of nitric oxide and plasma angiotensin II in postmenopausal women].
    Zheng X; He FF; Nie M; Sun ML; Ge QS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):635-8. PubMed ID: 12905695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate].
    Milewicz T; Krzysiek J; Rogatko I; Sztefko K; Stochmal E; Hubalewska-Dydejczyk A; Jach R; Radowicki S
    Ginekol Pol; 2011 Mar; 82(3):200-4. PubMed ID: 21735688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.
    Best PJ; Berger PB; Miller VM; Lerman A
    Ann Intern Med; 1998 Feb; 128(4):285-8. PubMed ID: 9471931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.
    Djurovic S; Os I; Hofstad AE; Abdelnoor M; Westheim A; Berg K
    J Intern Med; 2000 Feb; 247(2):279-85. PubMed ID: 10692092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.